Sumitomo Chemical unit Sumitomo Pharma rejects Gotham City Research report, sees no need to restate financials

Reuters2026/08/04 06:12

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Sumitomo Pharma, a Sumitomo Chemical subsidiary, acknowledged a Gotham City Research report published Aug. 3, 2026.
Sumitomo Pharma said it has not confirmed allegations of financial misstatements or inappropriate accounting.
Sumitomo Pharma said it has no plans to revise previously disclosed financial statements.
Financial statements received an unqualified audit opinion, according to the company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sumitomo Chemical Co. Ltd. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Sumitomo Chemical unit Sumitomo Pharma rejects Gotham City Research report, sees no need to restate financials

You may also like

Crypto prices